Flagship Pioneering Appoints Paul Parker as Managing Partner, Capital Solutions and Value Realization

Paul Parker has joined Flagship Pioneering as Managing Partner, Capital Solutions and Value Realization, bringing over 35 years of experience in banking, pharma, biotech, M&A, and corporate strategy. Parker will lead capital solutions efforts, fundraising activities, and manage relationships with investors, playing a key role on Flagship's senior leadership team. This appointment comes as Flagship enters its next phase of growth and development following the raise of its latest capital pool of $3.6B in July of this year.

Key Takeaways:

• Paul Parker has been appointed as Managing Partner, Capital Solutions and Value Realization at Flagship Pioneering, bringing over 35 years of experience in banking, pharma, biotech, M&A, and corporate strategy.
• Parker will lead all capital solutions efforts at Flagship, driving portfolio value realization, fundraising activities, and building and managing relationships with Limited Partners and strategic and financial investors.
• Parker has worked across multiple sectors and geographies, built and managed several multi-billion-dollar businesses, and led teams of several thousand employees.
• He previously served as Co-Chairman of the Global M&A Group for Goldman Sachs & Co. and Chairman and Head of Global M&A and Co-Head of Corporate Finance at Barclays Group Plc.
• Parker becomes Flagship's third Managing Partner, alongside Doug Cole and Stephen Berenson, and will play a key role on Flagship's senior leadership team.
• Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $75 billion in aggregate value, and is operating with $14 billion of assets under management.
• The current Flagship ecosystem comprises 43 companies, including Foghorn Therapeutics, Moderna, Omega Therapeutics, Sana Biotechnology, Generate Biomedicines, Inari, and Tessera Therapeutics.

Statistics:

• Flagship Pioneering has originated and fostered more than 100 scientific ventures, resulting in more than $75 billion in aggregate value.
• Flagship has raised a capital pool of $3.6B in July of this year.
• Flagship is operating with $14 billion of assets under management as of its latest capital raise.
• The current Flagship ecosystem comprises 43 companies.
• Paul Parker has over 35 years of experience in the life sciences industry in both banking, including pharma and biotech, as well as in M&A, corporate strategy, and organizational leadership.

Sources:

• Flagship Pioneering
• Harvard Business School
• University of North Carolina at Chapel Hill
• Clorox Company